Clinical Trial Update: [18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients

View source ↗

Summary

Clinical trial NCT06738862 evaluating [18F]-FD17 PET imaging of α-synuclein in α-synucleinopathy patients has completed, including Parkinson's disease, Multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy
• Parkinson Disease
• Rapid Eye Movement Sleep Behavior Disorder

Snippet

Sponsor: Ruijin Hospital | Conditions: α-synucleinopathy, Parkinson's Disease (PD) | Status: COMPLETED